UBS Group Issues Positive Forecast for Adient (NYSE:ADNT) Stock Price

Adient (NYSE:ADNTFree Report) had its price target boosted by UBS Group from $19.00 to $20.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has a neutral rating on the stock.

A number of other analysts have also recently weighed in on ADNT. Barclays dropped their price objective on shares of Adient from $24.00 to $21.00 and set an “equal weight” rating on the stock in a report on Wednesday, January 22nd. JPMorgan Chase & Co. reduced their price objective on Adient from $24.00 to $21.00 and set a “neutral” rating for the company in a research report on Monday. StockNews.com cut Adient from a “buy” rating to a “hold” rating in a research report on Wednesday, January 22nd. Wells Fargo & Company lowered Adient from an “overweight” rating to an “equal weight” rating and reduced their price target for the stock from $27.00 to $20.00 in a research report on Monday, December 16th. Finally, Bank of America lowered Adient from a “buy” rating to a “neutral” rating and lowered their price target for the company from $30.00 to $24.00 in a report on Thursday, November 21st. One equities research analyst has rated the stock with a sell rating and nine have given a hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $21.88.

Read Our Latest Report on Adient

Adient Price Performance

ADNT stock opened at $18.16 on Wednesday. Adient has a 52-week low of $16.28 and a 52-week high of $36.04. The company has a quick ratio of 0.90, a current ratio of 1.11 and a debt-to-equity ratio of 0.98. The company has a market capitalization of $1.52 billion, a PE ratio of 78.93, a P/E/G ratio of 0.28 and a beta of 2.16. The stock’s 50 day moving average is $18.01 and its two-hundred day moving average is $20.60.

Adient (NYSE:ADNTGet Free Report) last released its earnings results on Tuesday, January 28th. The company reported $0.27 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.05). Adient had a return on equity of 6.86% and a net margin of 0.12%. During the same period in the prior year, the company posted $0.31 EPS. Analysts predict that Adient will post 2.04 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Adient news, EVP James Conklin sold 11,500 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $20.25, for a total value of $232,875.00. Following the completion of the transaction, the executive vice president now directly owns 51,829 shares in the company, valued at $1,049,537.25. This trade represents a 18.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 0.72% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Adient

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Versant Capital Management Inc lifted its holdings in shares of Adient by 10,316.7% in the fourth quarter. Versant Capital Management Inc now owns 1,875 shares of the company’s stock valued at $32,000 after purchasing an additional 1,857 shares in the last quarter. R Squared Ltd purchased a new stake in Adient in the 4th quarter worth about $32,000. US Bancorp DE lifted its stake in Adient by 583.8% in the 3rd quarter. US Bancorp DE now owns 1,860 shares of the company’s stock worth $42,000 after acquiring an additional 1,588 shares in the last quarter. Signaturefd LLC boosted its position in Adient by 493.8% during the 3rd quarter. Signaturefd LLC now owns 2,191 shares of the company’s stock worth $49,000 after acquiring an additional 1,822 shares during the period. Finally, KBC Group NV grew its stake in Adient by 51.8% during the 3rd quarter. KBC Group NV now owns 3,328 shares of the company’s stock valued at $75,000 after acquiring an additional 1,136 shares in the last quarter. Institutional investors and hedge funds own 92.44% of the company’s stock.

About Adient

(Get Free Report)

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.

Read More

Analyst Recommendations for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.